Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Hematology · GGCX-Related Disorder

Recognizing Symptoms and Emergency Signs

At a Glance

GGCX-related disorder can cause bleeding from birth or after minor injuries, along with later skin laxity and eye changes. Sudden severe headache, vomiting, neurologic symptoms, digestive bleeding, significant head trauma, or sudden vision changes require urgent medical evaluation.

Symptoms of GGCX-related disorder (also known as VKCFD1 or GGCX-related PXE-like syndrome) vary widely between individuals. Because the GGCX gene affects both how your blood clots and how your connective tissues maintain their structure, you may experience a “dual phenotype”—meaning symptoms can appear in your blood, your skin, and your eyes [1][2].

Emergency Red Flags

Because your body may not produce enough active clotting factors, internal bleeding can become life-threatening very quickly.

WHAT TO DO: If you experience any of the symptoms below, or if you suffer any significant head trauma (even if you feel fine initially), you must:

  1. Call emergency services or go to the nearest emergency department immediately. Do not wait for a callback from your specialist.
  2. Tell emergency responders you have a congenital vitamin K-dependent factor deficiency.
  3. Hand them your hematologist-issued emergency plan letter.

Signs of Bleeding in the Brain

  • Sudden, severe headache [3]
  • Repeated vomiting [4]
  • Seizures, even if there is no prior history of epilepsy [4]
  • Confusion, extreme sleepiness, or difficulty waking up
  • Weakness or numbness in the face, arms, or legs, especially on one side
  • Bulging soft spot (fontanelle) in infants [3]

Signs of Digestive Tract Bleeding

  • Black, tarry, or foul-smelling stools (melena) [5]
  • Vomiting blood or material that looks like coffee grounds
  • Bright red blood in the stool or significant rectal bleeding [6]
  • Unexplained dizziness, fainting, or extreme paleness

Urgent Eye Symptoms

If you experience a new blind spot, wavy or distorted vision, new flashes or floaters, or sudden loss of central vision, seek same-day evaluation from an eye care specialist. These can be signs of abnormal blood vessel growth in the retina [7].

Medication Safety Warning

DO NOT take aspirin, ibuprofen, naproxen (NSAIDs), or any blood-thinning medications unless specifically instructed by your treating hematologist. These medications interfere with clotting and can drastically increase your risk of severe bleeding.

The Bleeding Phenotype

The “bleeding phenotype” refers to how the condition affects your blood’s ability to clot. This can range from mild bruising to severe, spontaneous bleeding [8].

  • Neonatal/Infant Symptoms: Some infants are diagnosed shortly after birth due to persistent bleeding despite routine neonatal vitamin K, bleeding from the injection site, or bleeding from the umbilical cord [9][8].
  • Childhood and Adulthood: You may notice frequent nosebleeds, easy bruising, or heavy menstrual periods. Minor injuries may bleed much longer than expected [10][11].
  • Surgical Risk: Significant bleeding may only become apparent during a major event, such as a tooth extraction or surgery, where the body’s clotting system is put to the test [8].

The Connective Tissue Phenotype

Unlike the bleeding symptoms which can start at birth, the connective tissue symptoms often develop and change as you age [12]. This happens because minerals slowly build up in the elastic fibers of your body [13].

Skin Changes

Skin manifestations are often the most common non-bleeding symptoms [2]. These typically appear in the second or third decade of life and include:

  • Loose or Redundant Skin: The skin may appear “too big” for the body or hang in folds (laxity) [13][14].
  • Leathery Folds: You may develop thick, leathery, or wrinkled folds of skin, particularly around the neck and underarms (axillae) [14].
  • Calcification: The elastic fibers in the skin can become mineralized, which a doctor can confirm via a skin biopsy [13].

Eye Findings

The same process that affects the skin can affect a thin layer in the back of the eye called Bruch’s membrane.

  • Angioid Streaks: These are small cracks or “streaks” in the membrane that can be seen during a dilated eye exam. They often appear during the teenage years or early adulthood and may grow over time [7][13].
  • Peau d’orange: This is a subtle change where the back of the eye looks mottled, like the skin of an orange. It is often the very first sign of eye involvement in younger patients [15].
  • Vision Loss: Over time, these streaks can lead to the growth of abnormal blood vessels that may leak or scar, potentially causing a loss of central vision [7][16].

Other Potential Manifestations

Because the GGCX enzyme is active throughout the body, some patients may experience other symptoms beyond bleeding and skin changes, though evidence is often limited to case reports:

  • Skeletal Changes: This can include shorter-than-average fingertips (distal hypoplasia) or small spots of calcium on the ends of bones (stippled epiphyses) in isolated reports [17].
  • Cardiac/Vascular: In rare cases, calcium can build up in the walls of blood vessels or affect heart valves [12][18]. Routine vascular screening is typically directed by symptoms.
  • Kidney Stones: While kidney stones are a concern in classic PXE, there is no clearly established routine kidney-stone surveillance strategy for GGCX-related disease. Testing is directed by symptoms rather than a universal requirement [19].

Common questions in this guide

Which symptoms of GGCX-related disorder require emergency care?
Seek emergency care for a sudden severe headache, repeated vomiting, seizures, confusion, extreme sleepiness, one-sided weakness, black stools, vomiting blood, significant rectal bleeding, fainting, or marked paleness. Significant head trauma requires immediate evaluation even if you initially feel well.
What should I do after a significant head injury if I have GGCX-related disorder?
Call emergency services or go to the nearest emergency department immediately, even if you feel fine at first. Tell responders that you have a congenital vitamin K-dependent factor deficiency and provide your hematologist-issued emergency plan letter.
What skin changes can GGCX-related disorder cause?
The skin may become loose or redundant, hang in folds, or develop thick, leathery, wrinkled areas, especially around the neck and underarms. These changes often appear in the second or third decade of life and may reflect mineral buildup in elastic fibers that can be evaluated with a skin biopsy.
What eye symptoms need same-day medical attention?
A new blind spot, wavy or distorted vision, new flashes or floaters, or sudden loss of central vision should prompt same-day evaluation by an eye-care specialist. These symptoms can be related to abnormal blood vessel growth associated with angioid streaks and may threaten central vision.
Can GGCX-related disorder cause bleeding after minor injuries or procedures?
Yes. Bleeding may appear as easy bruising, frequent nosebleeds, heavy menstrual periods, or bleeding that lasts much longer than expected after a small cut, dental work, or surgery. Infants may have persistent bleeding from an injection site or umbilical cord despite routine newborn vitamin K.
Which over-the-counter pain medicines should people with GGCX-related disorder avoid?
Do not take aspirin, ibuprofen, naproxen, or blood-thinning medicines unless your treating hematologist specifically approves them. These medicines can interfere with clotting and increase the risk of severe bleeding, so ask your healthcare team before using an over-the-counter pain reliever.
Why can bleeding symptoms occur before skin and eye changes?
Bleeding can begin at birth because the disorder affects the activation of clotting factors. Skin and eye findings often develop later because mineral buildup in elastic tissues accumulates over time.

Get notified when new evidence is published on Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 Phenotypes.

    Ghosh S, Oldenburg J, Czogalla-Nitsche KJ

    International journal of molecular sciences 2022; (23(2)) doi:10.3390/ijms23020798.

    PMID: 35054981
  2. 2

    [Partial research progress of GGCX pathogenic variation associated phenotypes].

    Shen G, Liu H, Shen Y, Xi S

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2022; (39(6)):646-650 doi:10.3760/cma.j.cn511374-20210430-00381.

    PMID: 35773773
  3. 3

    Familial vitamin K metabolism deficiency responsible for a congenital binder phenotype.

    Grammatopoulos K, Harroche A, Peduto C, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2025; (32(6)):420-422 doi:10.1016/j.arcped.2025.05.003.

    PMID: 40562611
  4. 4

    Neonatal Cholestasis Presenting With Seizures Associated With Vitamin K Deficiency: A Case Report.

    Shah BK, Paudel S

    Sage open pediatrics 2026; (13()):30502225261456572 doi:10.1177/30502225261456572.

    PMID: 42205297
  5. 5

    Late vitamin K deficiency bleeding in infants: five-year prospective study.

    Al-Zuhairy SH

    Jornal de pediatria 2021; (97(5)):514-519 doi:10.1016/j.jped.2020.09.003.

    PMID: 33064995
  6. 6

    Management of rare coagulation disorders in 2018.

    Jain S, Acharya SS

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2018; (57(6)):705-712 doi:10.1016/j.transci.2018.10.009.

    PMID: 30392819
  7. 7

    [Study of fundus examination by age in 158 pseudoxanthoma elasticum patients].

    Pipelart V, Leruez S, Martin L, et al.

    Journal francais d'ophtalmologie 2018; (41(7)):592-602 doi:10.1016/j.jfo.2018.03.003.

    PMID: 30143311
  8. 8

    Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors.

    Raharimanana A, Cunat S, Falaise C, et al.

    Hamostaseologie 2025; (45(5)):396-404 doi:10.1055/a-2567-3567.

    PMID: 40541254
  9. 9

    Congenital Combined Deficiency of the Vitamin K-dependent Clotting Factors (VKCFD): A Novel Gamma-glutamyl Carboxylase (GGCX) Mutation.

    Al Absi HS, Abdullah MF

    Journal of pediatric hematology/oncology 2019; (41(4)):e224-e226 doi:10.1097/MPH.0000000000001385.

    PMID: 30531603
  10. 10

    GGCX mutations show different responses to vitamin K thereby determining the severity of the hemorrhagic phenotype in VKCFD1 patients.

    Ghosh S, Kraus K, Biswas A, et al.

    Journal of thrombosis and haemostasis : JTH 2021; (19(6)):1412-1424 doi:10.1111/jth.15238.

    PMID: 33590680
  11. 11

    Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K-Dependent Coagulation Factors Deficiency.

    Perrone S, Raso S, Napolitano M

    Seminars in thrombosis and hemostasis 2025; (51(2)):170-179 doi:10.1055/s-0044-1792031.

    PMID: 39496305
  12. 12

    GGCX-Associated Phenotypes: An Overview in Search of Genotype-Phenotype Correlations.

    De Vilder EY, Debacker J, Vanakker OM

    International journal of molecular sciences 2017; (18(2)) doi:10.3390/ijms18020240.

    PMID: 28125048
  13. 13

    GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype.

    Li D, Ryu E, Saeidian AH, et al.

    The British journal of dermatology 2021; (184(6)):1170-1174 doi:10.1111/bjd.19576.

    PMID: 33000479
  14. 14

    [Pseudoxanthoma elasticum-like disease with deficiency of vitamin K-dependent clotting factors and cutis laxa features].

    Gusdorf L, Mitcov M, Maradeix S, et al.

    Annales de dermatologie et de venereologie 2016; (143(4)):279-83.

    PMID: 26944767
  15. 15

    The Natural History of Bruch's Membrane Calcification in Pseudoxanthoma Elasticum.

    Risseeuw S, van Leeuwen R, Imhof SM, et al.

    Ophthalmology science 2021; (1(1)):100001 doi:10.1016/j.xops.2020.100001.

    PMID: 37487136
  16. 16

    VISUAL ACUITY IN PSEUDOXANTHOMA ELASTICUM.

    Risseeuw S, Ossewaarde-van Norel J, Klaver CCW, et al.

    Retina (Philadelphia, Pa.) 2019; (39(8)):1580-1587 doi:10.1097/IAE.0000000000002173.

    PMID: 29652691
  17. 17

    GGCX-related congenital combined vitamin K-dependent clotting factors deficiency-1: Description of a fetus with chondrodysplasia punctata.

    Mathonnet A, Cunat S, Allias F, et al.

    American journal of medical genetics. Part A 2022; (188(1)):314-318 doi:10.1002/ajmg.a.62503.

    PMID: 34558179
  18. 18

    Calcification in dermal fibroblasts from a patient with GGCX syndrome accompanied by upregulation of osteogenic molecules.

    Okubo Y, Masuyama R, Iwanaga A, et al.

    PloS one 2017; (12(5)):e0177375 doi:10.1371/journal.pone.0177375.

    PMID: 28494010
  19. 19

    Mutation spectrum in the ABCC6 gene and genotype-phenotype correlations in a French cohort with pseudoxanthoma elasticum.

    Legrand A, Cornez L, Samkari W, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(8)):909-917 doi:10.1038/gim.2016.213.

    PMID: 28102862

This page is for informational purposes only and does not constitute medical advice. It cannot replace your hematologist’s emergency plan; seek urgent care for suspected bleeding, significant head trauma, or sudden vision changes.